Cannabinoids and cancer

Mini-Reviews in Medicinal Chemistry

Volumn 5, Issue 10, 2005, Pages 941-952

  Kogan, Natalya M ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Angiogenesis; Cancer; Cannabinoid; Endocannabinoid; Mechanisms

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; AJULEMIC ACID; ALPHA TOCOPHEROL; ANANDAMIDE; ANTINEOPLASTIC AGENT; CANNABIDIOL; CANNABIGEROL; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR ANTAGONIST; CAPSAZEPINE; CASPASE; CERAMIDE; CYCLOOXYGENASE 2; DEXANABINOL; DRONABINOL; ENDOCANNABINOID; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OLEAMIDE; PALMIDROL; PROLACTIN; RIMONABANT; STRESS ACTIVATED PROTEIN KINASE; UNINDEXED DRUG; VANILLOID RECEPTOR; VANILLOID RECEPTOR 1;

ANGIOGENESIS; ANTIEMETIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHEMOTHERAPY INDUCED EMESIS; COLORECTAL CANCER; DNA SYNTHESIS; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLIOMA CELL; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LEWIS CARCINOMA; NONHUMAN; PROSTATE CANCER; PROTEIN DEGRADATION; RECEPTOR AFFINITY; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CANNABINOIDS; CELL PROLIFERATION; DNA; GLIOMA; HUMANS; LUNG NEOPLASMS; NEOPLASMS, EXPERIMENTAL; RECEPTORS, DRUG;

EID: 24944465781     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955705774329555     Document Type: Review

References (117)

1. Gaoni, Y., Mechoulam, R. J. Am. Chem. Soc. 1964, 86, 1646.
2. Waller, C.W., Johnson, J.J., Buelke, J., Turner, C.E., Marihuana, an annotated bibliography. Res. Inst. Pharmacy Sci. Univ., Mississippi 1976.
3. Klein, T.W., Newton, C.A., Friedman, H. Pain Res. Manag., 2001, 6, 95.
4. Berdyshev, E.V. Chem. Phys. Lipids, 2000, 108, 169.
5. Berry, E.M., Mechoulam, R. Pharmacol. Ther., 2002, 95, 185.
6. Maccarrone, M., Falciglia, K., Di Rienzo, M., Finazzi-Agro, A Prostaglandins Leukot. Essent. Fatty Acids, 2002, 66, 309.
7. Smith, C.G., Asch, R.H. NIDA Res. Monogr., 1984, 44, 82.
8. Jarvinen, T., Pate, D.W., Laine, K. Pharmacol. Ther., 2002, 95, 203.
9. Jones, R.T. J. Clin. Pharmacol., 2002, 42, 58S.
10. Randall, M.D., Harris, D., Kendall, D.A., Ralevic, V. Pharmacol. Ther., 2002, 95, 191.
11. Mechoulam, R., Spatz M., Shohami, E. Sci. STKE, 2002, 129, RE5.
12. Croxford, J.L. CNS Drugs, 2003, 17, 179.
13. Fride, E. Prostaglandins Leukot Essent Fatty Acids, 2002, 66, 221.
14. Munson, A.E., Harris, L.S., Friedman, M.A., Dewey, W.L., Carchman, R.A. J. Natl. CancerInst., 1975, 55, 597.
15. Carchman, R.A., Harris, L.S., Munson, A.E. Cancer Res., 1976, 36, 95.
16. White, A.C., Munson, J.A., Munson, A.E., Carchman, R.A. J. Natl. Cancer Inst., 1976, 56, 655.
17. Friedman, M.A. Cancer Biochem. Biophys., 1977, 2, 51.
18. Tucker, A.N., Friedman, M.A. Res. Commun. Chem. Pathol. Pharmacol., 1977, 17, 703.
19. Dvilansky, A., Zolotov, Z., Herzliker, B., Nathan, I. Int. J. Tissue React., 1984, 6, 409.
20. Cabral, G.A., McNerney, P.J., Mishkin, E.M. Arch. Toxicol., 1987, 60, 439.
21. Murison, G., Chubb, C.B., Maeda, S., Gemmell, M.A., Huberman, E. Proc. Natl. Acad. Sci. USA, 1987, 84, 5414.
22. Rowley, J.T., Rowley, P.T. Life Sci., 1990, 46, 217.
23. Sanchez, C., Galve-Roperh, I., Canova, C., Brachet, P., Guzman, M. FEBS Lett., 1998, 436, 6.
24. Kolesnick, R.N., Kronke, M. Annu. Rev. Physiol., 1998, 60, 643.
25. Galve-Roperh, I., Sanchez, C., Cortes, M.L., Gomez, del Pulgar, T., Izquierdo, M., Guzman, M. Nat. Med., 2000, 6, 313.
26. Marshall, C.J. Nature, 1998, 392, 553.
27. York, R.D., Yao, H., Dillon, T., Ellig, C.L., Eckert, S.P., McCleskey, E. W., Stork, P.J.S. Nature, 1998, 392, 622.
28. Derkinderen, P., Enslen, H., Girault, J.A. Neuro Report, 1999, 10, R24.
29. Guzman, M., Galve-Ropherh, I., Sanchez, C. Trends Pharmacol. Sci., 2001, 22, 19.
30. Gomez del Pulgar, T., Velasco, G., Sanchez, C., Haro, A., Guzman, M. Biochem. J., 2002, 363, 183.
31. Sanchez, C., de Ceballos, M.L., Gomez del Pulgar, T., Rueda, D., Corbacho, C., Velasco, G., Galve-Roperh, I., Huffman, J.W., Ramony Cajal, S., Guzman, M. Cancer Res., 2001, 61, 5784.
32. Mechoulam, R., Ben-Shabat, S., Hanus, L., Fride, E., Vogel, Z., Bayewitch, M., Sulcova, A.E. J. Lipid Mediat. Cell Signal., 1996, 14, 45.
33. Showalter, V.M., Compton, D.R., Martin, B.R., Abood, M.E. J. Pharmacol. Exp. Ther., 1996, 278, 989.
34. Roberts, L.A., Christie, M.J., Connor, M. Br. J. Pharmacol., 2002, 137, 421.
35. Jacobsson, S.O., Wallin, T., Fowler, C.J. J. Pharmacol. Exp. Ther., 2001, 299, 951.
36. Maccarrone, M., Pauselli, R., di Rienzo, M., Finazzi-Agro, A. Biochem. J., 2002, 366, 137.
37. Recht, L.D., Salmonsen, R., Rosetti, R., Jang, T., Pipia, G., Kubiatowski, T., Karim, P., Ross, A.H., Zurier, R., Litofsky, N.S., Burstein, S. Biochem. Pharm., 2001, 62, 755.
38. Rueda, D., Galve-Roperh, I., Haro, A., Guzman, M. Mol. Pharmacol., 2000, 58, 814.
39. Matsuzawa, A., Ichijo, H. J. Biochem. (Tokyo), 2001, 130, 1.
40. Andoh, T. Cell Biochem. Biophys., 2000, 33, 181.
41. Chung, H.T., Pae, H.O., Choi, B.M., Billiar, T.R., Kim, Y.M. Biochem. Biophys. Res. Commun., 2001, 282, 1075.
42. Weidenfeld, J., Feldman, S., Mechoulam, R. Neuroendocrinology, 1994, 59, 110.
43. Wenger, T., Toth, B.E., Martin, B.R. Life Sci., 1995, 56, 2057.
44. Fernandez-Ruiz, J.J., Munoz, R.M., Romero, J., Villarma, M.A., Makriyannis, A., Ramos, J. Biochem. Pharmacol., 1997, 53, 1919.
45. Wenger, T., Jamali, K.A., Juaneda, C., Leonardelli, J., Tramu, G. Biochem. Biophys. Res. Commun., 1997, 237, 724.
46. De Petrocellis, L., Melck, D., Palmisano, A., Bisogno, T., Laezza, C., Bifulco, M., Di Marzo, V. Proc. Natl. Acad. Sci. USA, 1998, 95, 8375.
47. Melck, D., Rueda, D., Galve-Roperh, I., De Petrocellis, L., Guzman, M., Di Marzo, V. FEBS Lett., 1999, 463, 235.
48. Melck, D., De Petrocellis, L., Orlando, P., Bisogno, T., Laezza, C., Bifulco, M., Di Marzo, V. Endocrinology, 2000, 141, 118.
49. Bisogno, T., Katayama, K., Melck, D., Ueda, N., De Petrocellis, L., Yamamoto, S., Di Marzo, V. Eur. J. Biochem., 1998, 254, 634.
50. Di Marzo, V., Melck, D., Orlando, P., Bisogno, T., Zagoory O., Bifulco, M., Vogel, Z., De Petrocellis, L. Biochem. J., 2001, 358, 249.
51. Katayama, K., Ueda, N., Katoh, I., Yamamoto, S. Biochim. Biophys. Acta, 1999, 1440, 205.
52. De Petrocellis, L., Bisogno, T., Ligresti, A., Bifulco, M., Melck, D., Di Marzo, V. Fundam. Clin. Pharmacol., 2002, 16, 297.
53. Maccarrone, M., Lorenzon, T., Bari, M., Melino, G., Finazzi-Agro, A. J. Biol. Chem., 2000, 275, 31938.
54. Gomez del Pulgar, T., Velasco, G., Guzman, M. Biochem. J., 2000, 347, 369.
55. Engstrom, M., Karlsson, R., Jonsson, J.I. Exp. Hematol., 2003, 31, 316.
56. Yamaguchi, H., Wang, H.G. Oncogene, 2001, 20, 7779.
57. Cardone, M.H., Roy, N., Stennicke, H.R., Salvesen, G.S., Franke, T.F., Stanbridge, E., Frisch, S., Reed, J.C. Science, 1998, 282, 1318.
58. Sarker, K.P., Obara, S., Nakata, M., Kitijama, I., Maruyama, I. FEBS Lett., 2000, 472, 39.
59. Bifulco, M., Laezza, C., Portella, G., Vitale, M., Orlando, P., De Petrocellis, L., Di Marzo, V. FASEB J., 2001, 15, 2745.
60. Bos, J.L. Cancer Res., 1989, 49, 4682.
61. Ruiz, L., Miguel, A., Diaz-Lavada, I. FEBS Lett., 1999, 458, 400.
62. Baek, S.H., Kim, Y.O., Kwag, J.S., Choi, K.E., Jung, W.Y., Han, D.S. Arch. Pharm. Res., 1998, 21, 353.
63. McKallip, R.J., Lombard, K., Fisher, M., Martin, B.R., Ryu, S., Grant, S., Nagarkatti, P. S., Nagarkatti, M. Blood, 2002, 100, 627.
64. Zidek, Z. Eur. Cytokine Net., 1999, 10, 319.
65. Bouloumie, A., Drexler, H.C., Lafontan, M., Busse, R. Circ. Res., 1998, 83, 1059.
66. Sierra-Honigmann, M.R., Nath, A.K., Murakami, C., Garcia-Cardena, G., Papapetropoulos, A., Sessa, W.C., Madge, L.A., Schechner, J.S., Schwabb, M.B., Polverini, P.J., Flores-Riveros, J.R. Science, 1998, 281, 1683.
67. Blazquez, C., Casanova, M.L., Planas, A., Del Pulgar, T.G., Villanueva, C., Fernandez-Acenero, M.J., Aragones, J., Huffman, J.W., Jorcano, J.L., Guzman, M. FASEB J., 2003, 17, 529.
68. Portella, G., Laezza, C., Laccetti, P., De-Petrocellis, L., Di Marzo, V., Bifulco, M. FASEB J., 2003, 17, 1771.
69. Casanova, M.L., Larcher, F., Casanova, B., Murillas, R., Fernandez-Acenero, M.J., Villanueva, C., Martinez-Palacio, J., Ullrich, A., Conti, C.J., Jorcano, J.L. Cancer Res., 2002, 62, 3402.
70. Casanova, M.L., Blazquez, C., Martinez-Palacio, J., Villanueva, C., Fernandez-Acenero, M.J., Huffman, J.W., Jorcano, J.L., Guzman, M. J. Clin. Invest., 2003, 111, 43.
71. Guzman, M., Sanchez, C., Galve-Roperh, I. J. Mol. Med., 2001, 78, 613.
72. Guzman, M., Sanchez C., Galve-Roperh, I. Pharmacol. Ther., 2002, 95, 175.
73. Parolaro, D., Massi, P., Rubino, T., Monti, E. Prostaglan. Leuk. Essen. Fatty Acids, 2002, 66, 319.
74. Bifulco, M., Di-Marzo, V. Nat. Med., 2002, 8, 547.
75. Di Marzo, V., Melck, D., De Petrocellis, L., Bisogno, T. Prostaglandins. Other Lipid Mediat., 2000, 61, 43.
76. Maccarrone, M., Attina, M., Cartoni, A., Bari, M., Finazzi-Agro, A. J. Neurochem., 2001, 76, 594.
77. Mechoulam, R., Hanus, L. Pain Res. Manag., 2001, 6, 67.
78. Vigano, A., Watanabe, S., Bruera, E. Cancer Surv., 1994, 21, 99.
79. Inui, A. CA Cancer J Clin., 2002, 52, 72.
80. Gorter, R.W. Forsch Komplementarmed, 1999, 6, 21.
81. Walker, J.M., Strangman, N.M., Huang, S.M. Pain Res. Manag., 2001, 6, 74.
82. Mechoulam, R. Forsch Komplementarmed 1999, 6, 16.
83. De Petrocellis, L., Bisogno, T., Maccarone, M., Davis, J.B., Di Marzo, V. J. Biol. Chem., 2001, 276, 12856.
84. De Petrocellis, L., Bisogno, T., Davis, J.B., Petwee, R.G., Di Marzo, V. FEBS Lett., 2000, 483, 52.
85. Jonsson, K.O., Andersson, A., Jacobsson, S.O., Vandervoorde, S., Lambert, D.M., Fowler, C.J. Arch. Toxicol., 2003, 77, 201.
86. Mimeault, M., Pommery, N., Wattez, N., Bailly, C., Henichart, J.P. Prostate, 2003, 56, 1.
87. Sanches, M.G., Sanchez, A.M., Ruiz-Llorente, L., Diaz-Laviada, I. FEBS Lett., 2003, 555, 561.
88. Sarker, K.P., Biswas, K.K., Yamakuchi, M., Lee, K.Y., Hahiguchi, T., Kracht, M., Kitajima, I., Maruyama, I. J. Neurochem., 2003, 85, 50.
89. Ligresti, A., Bisogno, T., Matias, I., De Petrocellis, L., Cascio, M.G., Cosenza, V., D'argenio, G., Scaglione, G., Bifulco, M., Sorrentini, I., Di Marzo, V. Gastroenterology, 2003, 125, 973.
90. Fowler, C.J., Jonsson, K.O., Andersson, A., Juntunen, J., Jarvinen, A., Vandervoorde, S., Lambert, D.M., Jerman, J.C., Smart, D. Biochem. Pharmacol., 2003, 66, 757.
91. Massi, P., Vaccani, A., Ceruti, S., Colombo, A., Abbachio, M.P., Parolaro, D. JPET, 2004, 308, 838.
92. Sanchez, M., Ruiz-Llorente, L., Sanchez, A., Diaz-Lavada, I. Cell Signal., 2003, 15, 851.
93. Hart, S., Fisher, O., Ullrich, A. Cancer Res., 2004, 64, 1943.
94. Contassot, E., Tenan, M., Schnulinger, V., Pelte, M.F., Dietrich, P.Y. Ginecol. Oncol., 2004, 93, 182.
95. Joseph, J., Niggemann, B., Zaenker, K.S., Entschladen, F. Cancer Immunol Immunother, 2004, 53, 723.
96. Rubovitch, V., Gafni, M., Sarne, Y. Mol. Brain Res., 2004, 120, 138.
97. Gardner, B., Zhu, L.X., Sharma, S., Tashkin, D.P., Dubinett, S.M. FASEB J., 2003, 17, 2157.
98. Ramer, R., Weinzierl, U., Schwind, B., Brune, K., Hinz, B. Mol. Pharmacol., 2003, 64, 1189.
99. Schenning, M., Van Tiel, C.M., Van Marten, D., Stam, J.C., Gadella, B.M., Wirtz, K.W., Snoek, G.T. J. Lipid Res., 2004, 45, 1555.
100. Sarker, K.P., Maruyama, I. Cell Mol. Life Sci., 2003, 60, 1200.
101. Paton, W.D.M., Pertwee, R.G. In Marijuana: Chemistry, prarmacology, metabolism and clinical effects. 1973 New York, Academic Press.
102. Dewey, W.L. Pharmacol. Rev., 1986, 38, 151.
103. Fride, E. Brain Res., 1995, 697, 83.
104. Fride, E., Barg, J., Levy, R., Saya, D., Heldman, R., Mechoulam, R., Vogel, Z. J. Pharmacol. Exp. Ther., 1995, 272, 699.
105. Sulcova, E., Mechoulam, R., Fride, E. Pharmacol. Biochem. Behav., 1998, 59, 347.
106. Blazquez, C., Gonzalez-Feria, L., Alvarez, L., Haro, A., Casanova, M.L., Guzman, M. Cancer Res., 2004, 64, 5617.
107. Ellert-Miklaszewska, A., Kaminska, B., Konarska, L. Cell Signal., 2005, 17, 25.
108. Bifulco, M., Laezza, C., Valenti, M., Ligresti, A., Portella, G., DI Marzo, V. FASEB J., 2004, 18, 1606.
109. Kogan, N.M., Rabinowitz, R., Levi, P., Gibson, D., Sandor, P., Schlesinger, M., Mechoulam, R. J. Med. Chem., 2004, 47, 3800.
110. Benito, C., Nunez, E., Tolon, R.M., Carrier, E.J., Rabano, A., Hillard, C.J., Romero, J. J. Neurosci., 2003, 23, 11136.
111. Zhang, J., Hoffert, C., Vu, H.K., Groblewski, T., Ahmad, S., O'Donnell, D. Eur J. Neurosci., 2003, 17, 2750.
112. Contassot, E., Wilmotte, R., Tenan, M., Belkouch, M.C., Schnuriger, V., de Tribolet, N., Burkhardt, K., Dietrich, P.Y. J. Neuropathol. Exp. Neurol., 2004, 63, 956.
113. Hinz, B., Ramer, R., Eichele, K., Weinzierl, U., Brune, K. Biochem. Biophys. Res. Commun., 2004, 324, 621.
114. Bifulco, M., Laezza, C., Valenti, M., Ligresti, A., Portella, G., Di Marzo, V. FASEB J., 2004, 18, 1606.
115. Hinz, B., Ramer, R., Eichele, K., Weinzierl, U., Brune, K. Mol. Pharmacol., 2004, 66, 1643.
116. Kunos, G., Batkai, S., Offertaler, L., Mo, F., Liu, J., Karcher, J., Harvey-White, J. Chem. Phys. Lipids., 2002, 121, 45.
117. Offertaler, L., Mo, F.M., Batkai, S., Liu, J., Begg, M., Razdan, R.K., Martin, B.R., Bukoski, R.D., Kunos, G. Mol. Pharmacol., 2003, 63, 699.